C/O Karyopharm Therapeutics Inc., 85 Wells Avenue, Newton, MA
Summary
The estimated net worth of Kristin Abate is at least $128K dollars as of November 22, 2024. Kristin Abate is the Chief Accounting Officer of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $128K.
There are no insider transactions reported by Kristin Abate
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.